RNAC — Cartesian Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1453687 ·
Last close
$6.12
Market Cap
$186.68M
52W High
$11.00
52W Low
$5.60
ADV30
137,923
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -25,001,000 -11,472,000 294,305,000 122,975,000 424,772,000
Jun 2026 0 — -29,155,000 15,769,000 318,628,000 147,606,000 443,854,000
Mar 2026 78,000 — -26,499,000 -39,182,000 288,391,000 118,641,000 436,509,000
Dec 2025 947,000 — -21,939,000 -92,576,000 296,411,000 125,139,000 422,651,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-76,529,000
Investing CF
$-2,083,000
Financing CF
$65,925,000
CapEx
$-2,083,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.88
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-845,786,000
Inventory
—
Receivables
$196,000
ST Investments
—
EBIT TTM
$-52,883,000
Pretax Income TTM
$-161,084,000
Interest Exp TTM
$852,000
Analysts
6

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,025,000
EBITDA
$-99,809,000
Free Cash Flow
$-65,287,124
Enterprise Value
$167,048,624
Total Cash
$122,975,000
Total Debt
$60,336,000
Shares Out
30,503,005
Trailing EPS
$-4.78
Book Value
$-4.28
ROE
—
ROA
-19.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,797,000 -86,705,000 -130,302,000 296,411,000 422,651,000 -126,240,000 -73,941,000
Dec 2024 38,913,000 -36,318,000 -77,424,000 435,023,000 441,825,000 -6,802,000 -23,674,000
Dec 2023 26,004,000 -85,706,000 -219,710,000 305,050,000 745,234,000 -440,184,000 -51,161,000
Dec 2022 110,777,000 14,538,000 35,379,000 165,886,000 72,058,000 93,828,000 -31,631,000

TTM Snapshot

Revenues TTM
$1,477,000
NetIncome TTM
$-151,891,000
OpCashFlow TTM
—
Assets (Latest)
$318,628,000
Forward EPS
$-3.81

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $12.50 · spot: $6.30 · call volume: 56 · put volume: 179
Expected Move to 2027-02-19: ±$5.00 (79.37%) — implied range $1.30 – $11.30 · ATM straddle on $7.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ADCT ADC Therapeutics SA $189.89M $1.35 —
WHWK Whitehawk Therapeutics, Inc. $181.75M $3.08 —
TRDA Entrada Therapeutics, Inc. $194.19M $4.96 —
NATR NATURES SUNSHINE PRODUCTS INC $179.01M $10.33 —
SIGA SIGA TECHNOLOGIES INC $196.16M $2.73 —

News headlines (Yahoo Finance, 1h cache)

Bears are Losing Control Over Cartesian Therapeutics, Inc. (RNAC), Here's Why It's a 'Buy' Now
2026-11-16 13:55 · Yahoo
Wall Street Analysts See a 379.63% Upside in Cartesian Therapeutics, Inc. (RNAC): Can the Stock Really Move This High?
2026-11-10 13:55 · Yahoo
Cartesian Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-05 12:00 · Yahoo
Cartesian Therapeutics Announces New Employment Inducement Grant
2026-11-03 12:00 · Yahoo
Cartesian Therapeutics Announces New Employment Inducement Grants
2026-10-02 11:00 · Yahoo
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
2026-06-09 11:00 · Yahoo
uniQure (QURE) Reports Q3 Loss, Misses Revenue Estimates
2026-11-04 12:55 · Yahoo
Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates
2026-11-03 21:15 · Yahoo
Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis
2026-09-29 11:30 · Yahoo
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-06 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.